Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 79

Sort by

Sort Order Select

Journal Articles

TPA Use for Central Line De-Occlusion and Its Relationship to Symptomatic Venous Thromboembolism in Pediatric Leukemia Patients

Katherine Armstrong, MD, Kavitha Ramaswamy, MD, Victoria Cooley, MS, Linda M Gerber, PhD, Nicole Kucine, MD

Blood (2019) 134 (Supplement_1): 2111.

https://doi.org/10.1182/blood-2019-130315

Published: 2019

Journal Articles

How Caring for Toddlers and Young Children with Severe Haemophilia Impacts on Caregiver's Burden

Susan Halimeh, MD, Manuela Siebert, Sylvia Von Mackensen

Blood (2019) 134 (Supplement_1): 3461.

https://doi.org/10.1182/blood-2019-131185

Published: 2019

Journal Articles

Evaluation of the in Vitro Procoagulant Effect of Factor IX Concentrates in Patients on Prophylaxis with Emicizumab

Ihosvany Fernandez-Bello, María Teresa Alvarez Román, Mónica Martín, María Isabel Rivas Pollmar, Sara García Barcenilla, Carmen García Martínez, Tamara Cebanu, Paula Acuña, Raul Justo Sanz, Elena Monzón Manzano, Miguel A Canales, MD PhD, Nora Butta, PhD, Victor Jimenez-Yuste

Blood (2019) 134 (Supplement_1): 1118.

https://doi.org/10.1182/blood-2019-129983

Published: 2019

Journal Articles

Barriers and Facilitators to Chronic Red Cell Transfusion Therapy for Children with Sickle Cell Anemia: Results from the Displace Consortium

Alyssa M Schlenz, PhD, Shannon Phillips, PhD RN, Martina Mueller, PhD, Cathy Melvin, PhD MPH, Robert J. Adams, MD MS

Blood (2019) 134 (Supplement_1): 4697.

https://doi.org/10.1182/blood-2019-130646

Published: 2019

Journal Articles

A Retrospective Chart Review to Assess Indications, Risk Factors and Complications Associated with the Use of Indwelling Catheters in Pediatric Patients with Sickle Cell Disease - a Single Institution Experience

Chibuzo Ilonze, MD, Michael P Anderson, PhD, Alexander Stubblefield, Janna M. Journeycake, MD, Arpan Sinha, MBBS, MD

Blood (2019) 134 (Supplement_1): 4856.

https://doi.org/10.1182/blood-2019-130467

Published: 2019

Journal Articles

360 o View of a Day Hospital Program Performing Exchange Transfusion and Outpatient Pain Management on Adults with Sickle Cell Disease

Natasha Wright, CRNP, Susan M. Sylvester, RN, Gregory J Kato, MD, Enrico Novelli, MD, Maria Nepa, PA-C, Jude C Jonassaint, RN, Laura De Castro, MD MHSc

Blood (2019) 134 (Supplement_1): 5873.

https://doi.org/10.1182/blood-2019-122397

Published: 2019

Journal Articles

Therapeutic Plasma Exchange in Pediatrics for Immunologic Disorders; Tolerated and Safe Process for Pediatric Life-Threatening Conditions

Blood (2019) 134 (Supplement_1): 4986.

https://doi.org/10.1182/blood-2019-122106

Published: 2019

Journal Articles

The Role of Demographic and Social Factors on Decision Making in Patients with Relapsed and Refractory Multiple Myeloma Treated By Ixazomib, Lenalidomide and Dexamethasone

Jiri Minarik, MD PhD, Alexandra Jungova, Jan Straub, MD, Evzen Gregora, MD, Jana Bryknarova, Blanka Nemcova, Roman Hajek, MD

Blood (2019) 134 (Supplement_1): 5832.

https://doi.org/10.1182/blood-2019-130961

Published: 2019

Journal Articles

Real-World Data on the Use of rFIXFc in Subjects With Hemophilia B for Up to 3.7 Years Demonstrates Improved Bleed Control and Adherence With Reduced Treatment Burden

Amy Shapiro, Ateefa Chaudhury, Nisha Jain, Elisa Tsao, Chris Barnowski, Jing Feng, Doris Quon

Blood (2018) 132 (Supplement 1): 2493.

https://doi.org/10.1182/blood-2018-99-116909

Published: 2018

Journal Articles

Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?

Stéphanie Forté, MD MSc, FRCPC, Nafanta Fadiga, Olivia Pestrin, John Chinawaeze Aneke, MBBS, FMCPath, Shivani Bhat, MPH, Richard Ward, MBBS, MRCP, Kevin H. M. Kuo, MD MSc, FRCPC

Blood (2018) 132 (Supplement 1): 3518.

https://doi.org/10.1182/blood-2018-99-119716

Published: 2018

Journal Articles

Phlebitis after Parenteral Iron Sucrose Administration in Postpartum Women

Julia Ramos, MDPhD, Melissa Rosenstein, MD MS, Andrew Leavitt, MD

Blood (2018) 132 (Supplement 1): 1052.

https://doi.org/10.1182/blood-2018-99-113182

Published: 2018

Journal Articles

Iron Reduction Therapy in Ex-Thalassemics - Long Term Outcome

Fouzia N., DNB, DM, Gaurav Dixit, MD DM, Kavitha M Lakshmi, MSc, Anu Korula, MD DM, Aby Abraham, MD DM, Biju George, DM, Vikram Mathews, MD, Alok Srivastava, MD

Blood (2018) 132 (Supplement 1): 4591.

https://doi.org/10.1182/blood-2018-99-116171

Published: 2018

Journal Articles

Iron Overload after Hematopoietic Stem Cell Transplantation

Sara Casagranda, MD, Maria Chiara Magri, Stefania Galimberti, Fabio Pavan, MD, Sonia Bonanomi, MD, Corti Paola, MD, Nicoletta Masera, MD, Attilio Rovelli, MD, Adriana Balduzzi, MD

Blood (2018) 132 (Supplement 1): 4599.

https://doi.org/10.1182/blood-2018-99-114911

Published: 2018

Journal Articles

Outcome of Patients Receiving Extracorporeal Photopheresis for Steroid Resistant Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Alexandre Deloire, CRA, Daniela Revesz, MD, Youcef Chelgoum, MD, Mohamed El-Hamri, CRA, Franck-Emmanuel Nicolini, MD PhD, Hélène Labussière, MD, Olivier Hequet, MD

Blood (2018) 132 (Supplement 1): 5720.

https://doi.org/10.1182/blood-2018-99-118206

Published: 2018

Journal Articles

Development of a Concept-Driven Disease Impact Instrument from Patients with Hemophilia (Pediatric and Adult) and Caregivers

Jessica T. Markowitz, Esprit Ma, Paul Solari, Patrick Marquis, Amy D. Shapiro, MD, Barbara Konkle, MD, Peter Trask, Edmund Pezalla, Anna Christian, Michelle Rice, Wendy E. Owens, MA, Kimberly Haugstad, Yaping Xu, Richard H. Ko, Jennifer Whiteley, Robert F. Sidonio

Blood (2017) 130 (Supplement 1): 4732.

https://doi.org/10.1182/blood.V130.Suppl_1.4732.4732

Published: 2017

Journal Articles

Outcomes Following Placement of Venous Stents for Treatment of Thrombotic Venous Disease

Karen Breen, MD, Prakash Saha, Narayan Karanunithy, Beverley Hunt, Alexander Cohen, Vickie McDonald, James Uprichard, Michael Fay, MBBCHBAO, FRCPath, Stephen Black

Blood (2017) 130 (Supplement 1): 697.

https://doi.org/10.1182/blood.V130.Suppl_1.697.697

Published: 2017

Journal Articles

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Alessandra N L Prezotti, MD, Clarissa Ferreira, MD, Luciana Oliveira, MD PhD, Claudia Lorenzato, MD PhD, Maria P S V Orletti, Maria do Rosario Roberti, MD PhD, Rosangela Ribeiro, MD, Paula Ribeiro Villaca, MD PhD, Silmara Aparecida De Lima Montalvão, Samuel S Medina, MD, Gabriela G Yamaguti Hayakawa, MD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 2357.

https://doi.org/10.1182/blood.V130.Suppl_1.2357.2357

Published: 2017

Journal Articles

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children < 12 Years of Age with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Gili Kenet, MD, Andres Brainsky, MD, Jerry S. Powell, MD, Yanyan Li, PhD, Wilfried Seifert, PhD

Blood (2017) 130 (Supplement 1): 2370.

https://doi.org/10.1182/blood.V130.Suppl_1.2370.2370

Published: 2017

Journal Articles

Health-Related Quality of Life and Satisfaction of Children with Severe Hemophilia a Treated with Turoctocog Alfa Pegol (N8-GP)

Susan Kearney, MD, Tan P Pham, MPH, MS, Johan E Adalsteinsson, Andrea Landorph, Leslie J Raffini, MD MSCE

Blood (2017) 130 (Supplement 1): 2136.

https://doi.org/10.1182/blood.V130.Suppl_1.2136.2136

Published: 2017

Journal Articles

Providing Hemostasis for Long-Term Central Venous Access Device (LTCVAD) Placement in Patients with Factor VIII (FVIII) Inhibitors

Gennadii M. Galstian, Michail Spirin, MD, Nadezhda Zozulya, MD PhD, Elena Likhachyova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3671.

https://doi.org/10.1182/blood.V130.Suppl_1.3671.3671

Published: 2017

NARROW

TPA Use for Central Line De-Occlusion and Its Relationship to Symptomatic Venous Thromboembolism in Pediatric Leukemia Patients

How Caring for Toddlers and Young Children with Severe Haemophilia Impacts on Caregiver's Burden

Evaluation of the in Vitro Procoagulant Effect of Factor IX Concentrates in Patients on Prophylaxis with Emicizumab

Barriers and Facilitators to Chronic Red Cell Transfusion Therapy for Children with Sickle Cell Anemia: Results from the Displace Consortium

A Retrospective Chart Review to Assess Indications, Risk Factors and Complications Associated with the Use of Indwelling Catheters in Pediatric Patients with Sickle Cell Disease - a Single Institution Experience

360 o View of a Day Hospital Program Performing Exchange Transfusion and Outpatient Pain Management on Adults with Sickle Cell Disease

Therapeutic Plasma Exchange in Pediatrics for Immunologic Disorders; Tolerated and Safe Process for Pediatric Life-Threatening Conditions

The Role of Demographic and Social Factors on Decision Making in Patients with Relapsed and Refractory Multiple Myeloma Treated By Ixazomib, Lenalidomide and Dexamethasone

Real-World Data on the Use of rFIXFc in Subjects With Hemophilia B for Up to 3.7 Years Demonstrates Improved Bleed Control and Adherence With Reduced Treatment Burden

Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?

Phlebitis after Parenteral Iron Sucrose Administration in Postpartum Women

Iron Reduction Therapy in Ex-Thalassemics - Long Term Outcome

Iron Overload after Hematopoietic Stem Cell Transplantation

Outcome of Patients Receiving Extracorporeal Photopheresis for Steroid Resistant Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Development of a Concept-Driven Disease Impact Instrument from Patients with Hemophilia (Pediatric and Adult) and Caregivers

Outcomes Following Placement of Venous Stents for Treatment of Thrombotic Venous Disease

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children < 12 Years of Age with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Health-Related Quality of Life and Satisfaction of Children with Severe Hemophilia a Treated with Turoctocog Alfa Pegol (N8-GP)

Providing Hemostasis for Long-Term Central Venous Access Device (LTCVAD) Placement in Patients with Factor VIII (FVIII) Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only